Personal information

Verified email domains

Activities

Education and qualifications (2)

University of Toronto: ON, ON, CA

2021-09-01 to present | Ph.D. (Immunology)
Education
Source: Self-asserted source
Yangmin Qiu

China Pharmaceutical University: Nanjing, CN

2016-09-01 to 2020-07-01 | Bachelor of Science (School of Pharmacy)
Education
Source: Self-asserted source
Yangmin Qiu

Works (6)

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity

Nature Communications
2021-11-04 | Journal article
Contributors: Yunqian Qiao; Yangmin Qiu; Jie Ding; Nana Luo; Hao Wang; Xiaomin Ling; Jiya Sun; Zhihai Wu; Yisen Wang; Yanpeng Liu et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis

Pharmacological Research
2020 | Journal article
EID:

2-s2.0-85086604438

Part of ISSN: 10961186 10436618
Contributors: Cao, Y.; Cao, W.; Qiu, Y.; Zhou, Y.; Guo, Q.; Gao, Y.; Lu, N.
Source: Self-asserted source
Yangmin Qiu via Scopus - Elsevier

The Application of Ferroptosis in Diseases

Pharmacological Research
2020 | Journal article
EID:

2-s2.0-85085603352

Part of ISSN: 10961186 10436618
Contributors: Qiu, Y.; Cao, Y.; Cao, W.; Jia, Y.; Lu, N.
Source: Self-asserted source
Yangmin Qiu via Scopus - Elsevier

CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK

Oncogene
2020-09-10 | Journal article
Contributors: Binyan Lin; Yongxu Li; Tiepeng Wang; Yangmin Qiu; Zhenzhong Chen; Kai Zhao; Na Lu
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Correction to: Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer (Journal of Experimental and Clinical Cancer Research (2018) 37 (282) DOI: 10.1186/s13046-018-0960-7)

Journal of Experimental and Clinical Cancer Research
2019 | Journal article
EID:

2-s2.0-85074741682

Part of ISSN: 17569966
Contributors: Yao, Y.; Guo, Q.; Cao, Y.; Qiu, Y.; Tan, R.; Yu, Z.; Zhou, Y.; Lu, N.
Source: Self-asserted source
Yangmin Qiu via Scopus - Elsevier

Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer.

Journal of experimental & clinical cancer research : CR
2018-11-26 | Journal article
Part of PMID: 30477536
Part of PMC: PMC6258160
Source: Self-asserted source
Yangmin Qiu
grade
Preferred source (of 2)‎